Contemporary Treatment of Metastatic Renal Cell Carcinoma

por Stukalin, Igor, Alimohamed, Nimira, Heng, Daniel Y.C.
Publicado 2016

New approaches to first-line treatment of advanced renal cell carcinoma

por George, Daniel J., Lee, Chung-Han, Heng, Daniel
Publicado 2021

Review of the Interaction Between Body Composition and Clinical Outcomes in Metastatic Renal Cell Cancer Treated With Targeted Therapies

por Yip, Steven M., Heng, Daniel Y.C., Tang, Patricia A.
Publicado 2016

Cancer Patient Care during COVID-19

por Harky, Amer, Chiu, Chun Ming, Yau, Thomas Ho Lai, Lai, Sheung Heng Daniel
Publicado 2020

Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis

por Takemura, Kosuke, Yonekura, Satoru, Downey, Laura E., Evangelopoulos, Dimitris, Heng, Daniel Y.C.
Publicado 2022

In Reply

por de Velasco, Guillermo, Culhane, Aedín C., Heng, Daniel Y.C., Signoretti, Sabina, Choueiri, Toni K.
Publicado 2017

The Effects of COVID-19 on Cancer Care Provision: A Systematic Review

por Alom, Samiha, Chiu, Chun Ming, Jha, Ashwarya, Lai, Sheung Heng Daniel, Yau, Thomas Ho Lai, Harky, Amer
Publicado 2021

Mutational signatures among young-onset testicular cancers

por Mealey, Nicole E., O’Sullivan, Dylan E., Peters, Cheryl E., Heng, Daniel Y. C., Brenner, Darren R.
Publicado 2021

Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced Melanoma

por Gupta, Mehul, Stukalin, Igor, Meyers, Daniel, Goutam, Sid, Heng, Daniel Y. C., Cheng, Tina, Monzon, Jose, Navani, Vishal
Publicado 2023

Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis

por Bosma, Nicholas A., Warkentin, Matthew T., Gan, Chun Loo, Karim, Safiya, Heng, Daniel Y.C., Brenner, Darren R., Lee-Ying, Richard M.
Publicado 2022

Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review

por Lalani, Aly-Khan A., Heng, Daniel Y. C., Basappa, Naveen S., Wood, Lori, Iqbal, Nayyer, McLeod, Deanna, Soulières, Denis, Kollmannsberger, Christian
Publicado 2022

Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab

por Goutam, Siddhartha, Stukalin, Igor, Ewanchuk, Benjamin, Sander, Michael, Ding, Philip Q., Meyers, Daniel E., Heng, Daniel, Cheung, Winson Y., Cheng, Tina
Publicado 2022

Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies

por Cusano, Ellen, Wong, Chelsea, Taguedong, Eddy, Vaska, Marcus, Abedin, Tasnima, Nixon, Nancy, Karim, Safiya, Tang, Patricia, Heng, Daniel Y. C., Ezeife, Doreen
Publicado 2021

Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma

por Woo, Taylor E., Stukalin, Igor, Ding, Philip Q., Goutam, Siddhartha, Sander, Michael, Ewanchuk, Benjamin, Cheung, Winson Y., Heng, Daniel Y. C., Cheng, Tina
Publicado 2023

Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries

por Giles, Rachel, Maskens, Deborah, Bick, Robert, Martinez, Robin, Packer, Malcolm, Heng, Daniel, Larkin, James, Bex, Axel, Jewett, Michael, Jonasch, Eric, MacLennan, Sara
Publicado 2022

Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational Studies

por Heng, Daniel Y., Signorovitch, James, Swallow, Elyse, Li, Nanxin, Zhong, Yichen, Qin, Paige, Zhuo, Daisy Y., Wang, Xufang, Park, Jinhee, Stergiopoulos, Sotirios, Kollmannsberger, Christian
Publicado 2014

Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors

por Sander, Michael S., Stukalin, Igor, Vallerand, Isabelle A., Goutam, Siddhartha, Ewanchuk, Benjamin W., Meyers, Daniel E., Pabani, Aliyah, Morris, Don G., Heng, Daniel Y. C., Cheng, Tina
Publicado 2021

Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta

por Heer, Emily, Ruan, Yibing, Boyne, Devon J., Jarada, Tamer N., Heng, Daniel, Henning, Jan-Willem, Morris, Donald M., O’Sullivan, Dylan E., Cheung, Winson Y., Brenner, Darren R.
Publicado 2023

The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institut...

por Kaiser, Jeenan, Li, Haocheng, North, Scott A., Leibowitz-Amit, Raya, Seah, Jo-An, Morshed, Nisha, Chau, Caroline, Lee-Ying, Richard, Heng, Daniel Y.C., Sridhar, Srikala, Crabb, Simon J., Alimohamed, Nimira S.
Publicado 2018

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors

por Meyers, Daniel E., Stukalin, Igor, Vallerand, Isabelle A., Lewinson, Ryan T., Suo, Aleksi, Dean, Michelle, North, Scott, Pabani, Aliyah, Cheng, Tina, Heng, Daniel Y.C., Bebb, D. Gwyn, Morris, Don G.
Publicado 2019